Sinopharm Tech Holdings Limited (Stock Code: 8156) has issued a notice for its Annual General Meeting (AGM). The meeting is scheduled for 19 December 2025 at 11:00 a.m. and will be held at Units 1302–3, 13/F, Ruttonjee House, Ruttonjee Centre, 11 Duddell Street, Central, Hong Kong.

Shareholders will be asked to receive and consider the audited consolidated financial statements, together with the directors’ and independent auditors’ reports, for the year ended 30 June 2025. The agenda also includes resolutions to re-elect certain board members, appoint new independent non-executive directors, and authorize the board to set directors’ and auditors’ remuneration. Suya WWC CPA Limited is proposed for re-appointment as the Company’s auditors.

The AGM notice further covers special business regarding the board’s general mandates to allot and issue shares, as well as to repurchase shares, subject to specified conditions and limits. An extension of the general mandate, contingent upon the passing of the allotment and repurchase resolutions, will also be considered. Shareholders of record as of 15 December 2025 will be entitled to attend, speak, and vote at the meeting.